BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 35622156)

  • 1. Endocytic trafficking of GAS6-AXL complexes is associated with sustained AKT activation.
    Poświata A; Kozik K; Miączyńska M; Zdżalik-Bielecka D
    Cell Mol Life Sci; 2022 May; 79(6):316. PubMed ID: 35622156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway.
    Sawabu T; Seno H; Kawashima T; Fukuda A; Uenoyama Y; Kawada M; Kanda N; Sekikawa A; Fukui H; Yanagita M; Yoshibayashi H; Satoh S; Sakai Y; Nakano T; Chiba T
    Mol Carcinog; 2007 Feb; 46(2):155-64. PubMed ID: 17186543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer.
    Tanaka M; Siemann DW
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.
    Zdżalik-Bielecka D; Poświata A; Kozik K; Jastrzębski K; Schink KO; Brewińska-Olchowik M; Piwocka K; Stenmark H; Miączyńska M
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer.
    Song X; Akasaka H; Wang H; Abbasgholizadeh R; Shin JH; Zang F; Chen J; Logsdon CD; Maitra A; Bean AJ; Wang H
    J Biol Chem; 2020 Feb; 295(8):2348-2358. PubMed ID: 31959629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas6-induced tissue factor expression in endothelial cells is mediated through caveolin-1-enriched microdomains.
    Laurance S; Aghourian MN; Jiva Lila Z; Lemarié CA; Blostein MD
    J Thromb Haemost; 2014; 12(3):395-408. PubMed ID: 24354620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells.
    Hasanbasic I; Cuerquis J; Varnum B; Blostein MD
    Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1207-13. PubMed ID: 15130893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
    Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
    Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt.
    Melaragno MG; Cavet ME; Yan C; Tai LK; Jin ZG; Haendeler J; Berk BC
    J Mol Cell Cardiol; 2004 Oct; 37(4):881-7. PubMed ID: 15380678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bemcentinib and Gilteritinib Inhibit Cell Growth and Impair the Endo-Lysosomal and Autophagy Systems in an AXL-Independent Manner.
    Zdżalik-Bielecka D; Kozik K; Poświata A; Jastrzębski K; Jakubik M; Miączyńska M
    Mol Cancer Res; 2022 Mar; 20(3):446-455. PubMed ID: 34782372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance.
    Baumann C; Ullrich A; Torka R
    Mol Oncol; 2017 Oct; 11(10):1430-1447. PubMed ID: 28675785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas6 attenuates lipopolysaccharide‑induced TNF‑α expression and apoptosis in H9C2 cells through NF‑κB and MAPK inhibition via the Axl/PI3K/Akt pathway.
    Li M; Ye J; Zhao G; Hong G; Hu X; Cao K; Wu Y; Lu Z
    Int J Mol Med; 2019 Sep; 44(3):982-994. PubMed ID: 31524235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AXL regulates mesothelioma proliferation and invasiveness.
    Ou WB; Corson JM; Flynn DL; Lu WP; Wise SC; Bueno R; Sugarbaker DJ; Fletcher JA
    Oncogene; 2011 Apr; 30(14):1643-52. PubMed ID: 21132014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.
    Antony J; Tan TZ; Kelly Z; Low J; Choolani M; Recchi C; Gabra H; Thiery JP; Huang RY
    Sci Signal; 2016 Oct; 9(448):ra97. PubMed ID: 27703030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.
    Kimani SG; Kumar S; Bansal N; Singh K; Kholodovych V; Comollo T; Peng Y; Kotenko SV; Sarafianos SG; Bertino JR; Welsh WJ; Birge RB
    Sci Rep; 2017 Mar; 7():43908. PubMed ID: 28272423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages.
    Gustafsson A; Fritz HKM; Dahlbäck B
    Exp Cell Res; 2017 Jun; 355(1):47-56. PubMed ID: 28327411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.
    Ishikawa M; Sonobe M; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Date H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S467-76. PubMed ID: 23242819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.
    Kirane A; Ludwig KF; Sorrelle N; Haaland G; Sandal T; Ranaweera R; Toombs JE; Wang M; Dineen SP; Micklem D; Dellinger MT; Lorens JB; Brekken RA
    Cancer Res; 2015 Sep; 75(18):3699-705. PubMed ID: 26206560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies.
    Kariolis MS; Miao YR; Diep A; Nash SE; Olcina MM; Jiang D; Jones DS; Kapur S; Mathews II; Koong AC; Rankin EB; Cochran JR; Giaccia AJ
    J Clin Invest; 2017 Jan; 127(1):183-198. PubMed ID: 27893463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.